Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
37.66 USD | -0.29% | +2.67% | +4.90% |
Apr. 23 | Morgan Stanley Adjusts Exelon's Price Target to $38 From $37, Keeps Equalweight Rating | MT |
Apr. 22 | Scotiabank Adjusts Exelon's Price Target to $37 From $39 | MT |
Financials (USD)
Sales 2024 * | 21.49B | Sales 2025 * | 22B | Capitalization | 37.65B |
---|---|---|---|---|---|
Net income 2024 * | 2.45B | Net income 2025 * | 2.64B | EV / Sales 2024 * | 3.89 x |
Net Debt 2024 * | 46.02B | Net Debt 2025 * | 48.82B | EV / Sales 2025 * | 3.93 x |
P/E ratio 2024 * |
15.4
x | P/E ratio 2025 * |
14.3
x | Employees | 19,962 |
Yield 2024 * |
4.05% | Yield 2025 * |
4.3% | Free-Float | 99.67% |
Latest transcript on Exelon Corporation
1 day | -0.29% | ||
1 week | +2.67% | ||
Current month | +0.24% | ||
1 month | +2.20% | ||
3 months | +7.91% | ||
6 months | -3.44% | ||
Current year | +4.90% |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.58% | 1 M€ | -.--% | - | |
2.45% | 610 M€ | -0.63% | ||
1.56% | 18 M€ | +3.79% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 37.66 | -0.29% | 3,958,519 |
24-04-24 | 37.77 | +0.56% | 5,061,364 |
24-04-23 | 37.56 | -0.29% | 5,700,331 |
24-04-22 | 37.67 | +0.32% | 5,174,426 |
24-04-19 | 37.55 | +2.37% | 6,126,503 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.90% | 37.65B | |
+10.14% | 137B | |
+6.06% | 81.33B | |
-2.15% | 77.24B | |
+2.05% | 76.4B | |
-9.57% | 65.93B | |
+60.84% | 59.25B | |
+6.94% | 45.74B | |
+8.45% | 42.69B | |
0.00% | 40.35B |
- Stock Market
- Equities
- EXC Stock